Intellectual property marketplaces and how they work : evidence from German pharmaceutical firms

Birgitte Andersen, Federica Rossi and Johannes Stephan

This article examines a sample of German pharmaceutical firms to highlight the strategic reasons why firms participate in various intellectual property (IP) marketplaces, both proprietary (patents and copyrights) and non-proprietary (open source and non-patented technology). The obstacles that prevent these marketplaces from functioning efficiently are also investigated. The analysis suggests that IP policy must embrace all IP forms and must recognise that IP marketplaces do not work "automatically" but suffer many institutional failures.

MoreLess

Year of publication:	2010
Authors:	Andersen, Birgitte ; Rossi, Federica ; Stephan, Johannes
Published in:	Intereconomics : review of European economic policy. - Warsaw, Poland : Sciendo, ISSN 1613-964X, ZDB-ID 2066476-X. - Vol. 45.2010, 1, p. 35-47
Subject:	Deutschland \| Germany \| Pharmaindustrie \| Pharmaceutical industry \| Immaterialgüterrechte \| Intellectual property rights \| Arzneimittel \| Pharmaceuticals \| Patentrecht \| Patent law \| Markteintritt \| Market entry \| Institutionelle Infrastruktur \| Institutional infrastructure \| Marktstruktur \| Market structure

freely available

Full text |

More access options

doi.org

Check Google Scholar

In libraries world-wide (WorldCat)

In German libraries (KVK)

subito order

I need help

Type of publication:	Article
Type of publication (narrower categories):	Aufsatz in Zeitschrift ; Article in journal
Language:	English
Notes:	Systemvoraussetzungen: Acrobat Reader
Other identifiers:	10.1007/s10272-010-0323-x [DOI] hdl:10419/66549 [Handle]
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10009659550